Artículos por temáticas

Predicting Disease Onset from Mutation Status Using Proband and Relative Data with Applications to Huntington's Disease.

Chen T, Wang Y, Ma Y, Marder K, Langbehn DR.

J Probab Stat. 2012 Jan 1;2012. pii: 375935.

Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?

Banaszkiewicz K, Sitek EJ, Rudzińska M, Sołtan W, Sławek J, Szczudlik A.

J Neural Transm (Vienna). 2012 Nov;119(11):1361-5. doi: 10.1007/s00702-012-0787-x.

Operant-based instrumental learning for analysis of genetically modified models of Huntington's disease.

Trueman RC, Dunnett SB, Brooks SP.

Brain Res Bull. 2012 Jun 1;88(2-3):261-75. doi: 10.1016/j.brainresbull.2011.03.015. Review.

Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study.

Tada M, Coon EA, Osmand AP, Kirby PA, Martin W, Wieler M, Shiga A, Shirasaki H, Tada M, Makifuchi T, Yamada M, Kakita A, Nishizawa M, Takahashi H, Paulson HL.

Acta Neuropathol. 2012 Nov;124(5):749-60. doi: 10.1007/s00401-012-1005-5.

Journal of Huntington's Disease.

Leavitt BR, Thompson LM.

J Huntingtons Dis. 2012;1(1):1. doi: 10.3233/JHD-2012-120001. No abstract available.

Prevalence of Huntington's disease gene CAG repeat alleles in sporadic amyotrophic lateral sclerosis patients.

Ramos EM, Keagle P, Gillis T, Lowe P, Mysore JS, Leclerc AL, Ratti A, Ticozzi N, Gellera C, Gusella JF, Silani V, Alonso I, Brown RH Jr, MacDonald ME, Landers JE.

Amyotroph Lateral Scler. 2012 May;13(3):265-9. doi: 10.3109/17482968.2011.653573.

Perceived stress in prodromal Huntington disease.

Downing N, Smith MM, Beglinger LJ, Mills J, Duff K, Rowe KC, Epping E, Paulsen JS; PREDICT-HD Investigators of Huntington Study Group..

Psychol Health. 2012;27(2):196-209. doi: 10.1080/08870446.2010.529141.

Clinical predictors of driving status in Huntington's disease.

Beglinger LJ, Prest L, Mills JA, Paulsen JS, Smith MM, Gonzalez-Alegre P, Rowe KC, Nopoulos P, Uc EY.

Mov Disord. 2012 Aug;27(9):1146-52. doi: 10.1002/mds.25101.

The Patient Education Program for Huntington's Disease (PEP-HD).

A'Campo LE, Spliethoff-Kamminga NG, Roos RA.

J Huntingtons Dis. 2012;1(1):47-56. doi: 10.3233/JHD-2012-120002.

Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.

Ehrlich ME.

Neurotherapeutics. 2012 Apr;9(2):270-84. doi: 10.1007/s13311-012-0112-2. Review.

Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease.

Du X, Leang L, Mustafa T, Renoir T, Pang TY, Hannan AJ.

Transl Psychiatry. 2012 Jul 3;2:e133. doi: 10.1038/tp.2012.58. Erratum in: Transl Psychiatry. 2012;2:e144.

[Schizophrenia-like psychotic symptoms in a patient with confirmed Huntington's disease: a case report].

Grabski B, Siwek M, Dudek D, Jaeschke R, Banaszkiewicz K.

Psychiatr Pol. 2012 Jul-Aug;46(4):665-75. Polish.

Psychiatric disorders in Huntington's disease: a 2-year follow-up study.

Reedeker W, van der Mast RC, Giltay EJ, Kooistra TA, Roos RA, van Duijn E.

Psychosomatics. 2012 May-Jun;53(3):220-9. doi: 10.1016/j.psym.2011.12.010.

Infusion of Sydenham's chorea antibodies in striatum with up-regulated dopaminergic receptors: a pilot study to investigate the potential of SC antibodies to increase dopaminergic activity.

Doyle F, Cardoso F, Lopes L, Mendes M, Dias F, Cruz L, Tavares R, Camargos A, Carneiro M, Dias-Lopes C, Chávez-Olórtegui C.

Neurosci Lett. 2012 Aug 15;523(2):186-9. doi: 10.1016/j.neulet.2012.06.073.

Model mammals. Sheep are helping scientists gain ground against Huntington's disease.

Yuhas D.

Sci Am. 2012 Dec;307(6):17. No abstract available.